Folate-Targeted PEGylated Magnetoliposomes for Hyperthermia-Mediated Controlled Release of Doxorubicin

• Auteurs principaux: Emílio R. Cintra (Auteur), Tacio G. Hayasaki (Auteur), Ailton A. Sousa-Junior (Auteur), Artur C. G. Silva (Auteur), Marize C. Valadares (Auteur), Andris F. Bakuzis (Auteur), Sebastião A. Mendanha (Auteur), Eliana M. Lima (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Doxorubicin (DOX) is a chemotherapeutic agent commonly used for the treatment of solid tumors. However, the cardiotoxicity associated with its prolonged use prevents further adherence and therapeutic efficacy. By encapsulating DOX within a PEGylated liposome, Doxil® considerably decreased DOX cardio...